Announcement
20 Nov 2020
In November 2020, the European Union signed an Advanced Purchase Agreement (APA) with BioNTech-Pfizer for acquiring doses of the company’s COVID-19 vaccine. The agreement was published in 2021.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
20 Nov 2020
Revocation date:
20 Nov 2022
Updated: 20 Nov 2020
Local operations incentive
On 20 November 2020, the EU and BioNTech-Pfizer signed an Advanced Purchase Agreement (APA) for the production, purchase and supply of the company’s COVID-19 vaccine known as "COMIRNATY". Notably, ...
Sign in to see more
Related State Acts
29 Jan 2021
EU: Commission adopts temporary export authorisation for COVID-19 vaccines
30 Nov 2020
EU: COVID-19 Advanced Purchase Agreement with CureVac includes localisation requirement
18 Sep 2020
EU: Advanced Purchase Agreement with Sanofi-GSK includes localisation incentive
27 Aug 2020
EU: COVID-19 Advanced Purchase Agreement with AstraZeneca includes localisation requirement
Threads
See all
This state act is not part of any Thread yet.